A Cymbalta withdrawal lawsuit has been filed against Eli Lilly and Co. by two Kentucky residents who allege they experienced severe antidepressant discontinuation syndrome after taking the popular depression medication.

Plaintiffs Denise D. and Christopher H. allege that they suffered several injuries because they developed Cymbalta withdrawal syndrome. These Cymbalta injuries include physical, emotional, and psychological injuries; past and future pain and/or suffering; past and future mental anguish; decreased enjoyment of life; past and future medical expenses; and loss of consortium.

Denise was prescribed Cymbalta to treat her panic attacks and depression on October 2013. In March of the following year, Denise stopped taking Cymbalta and within a few days began to experience severe Cymbalta withdrawal symptoms.

According to the Cymbalta withdrawal lawsuit:

“Plaintiff [Denise D.] experienced extreme mood swings, agitation, irritability, anger, psychosis, electric shock-like sensations in her head, commonly known as ‘brain zaps,’ nightmares, sleep disturbances, insomnia, vertigo, dizziness, suicidal thoughts, self-mutilation, violent outbursts, and nausea.”

Denise claims that had Eli Lilly done its job and informed users of the actual risk of Cymbalta withdrawal syndrome, her doctor would not have prescribed her the antidepressant and she would never have suffered the Cymbalta side effects.

Christopher was also prescribed Cymbalta for depression and anxiety sometime in 2007 and began to taper off his use of the Eli Lilly antidepressant between March and July 2014.

According to the Cymbalta withdrawal lawsuit:

“Despite tapering, Plaintiff [Christopher H.] experienced agoraphobia, ringing in the ears (tinnitus), sickness to his stomach, suicidal thoughts, flu-like symptoms, dysphoria, waves of anxiety, visual flashes of light which made him panic, and strange feelings in the back of his head.”

Christopher similarly alleges that Eli Lilly neglected to inform him and other consumers of the possible Cymbalta withdrawal side effects. Had the company done their due diligence to inform him, his Cymbalta withdrawal injuries could have been avoided.

The plaintiffs jointly bring several allegations against Eli Lilly in this Cymbalta withdrawal lawsuit, including negligence, design defect, failure to warn, negligent misrepresentation, fraud, breach of and implied warranty.

The Cymbalta Withdrawal Lawsuit is Case No. 1:15-cv-00365-SEB-DKL, in the U.S. District Court for the Southern District of Indiana.

Cymbalta Antidepressant Discontinuation Syndrome

Cymbalta is a popular antidepressant medication that is designed, manufactured, and sold by Eli Lilly and Co. Since its FDA approval, Cymbalta has been regularly prescribed to treat numerous physical and psychological conditions, such as anxiety, fibromyalgia, chronic muscle and bone pain, and depression symptoms.

However, reports suggest Eli Lilly has not been completely honest with doctors and consumers about the prevalence of Cymbalta withdrawal symptoms.

A Cymbalta withdrawal symptoms drug study published in 2005 suggests that 51 percent of patients using Cymbalta have experiencing mild to severe antidepressant discontinuation syndrome symptoms. Additionally, up to 17 percent of the patients who participated in this Cymbalta withdrawal syndrome study allegedly experienced the more severe withdrawal symptoms associated with Cymbalta antidepressant withdrawal.

Some Cymbalta withdrawal side effects include:

• Severe nausea
• Vomiting
• Dizziness, light-headedness, vertigo
• Headaches
• Hot and cold flashes
• Mood swings, anxiety, irritability, hostility
• Nightmares
• Electric-shock-like sensations in the brain
• Tingling, tickling, prickling, pricking, or burning sensations of the skin
• Tremors, shaking hands
• Visual disturbances

As a result of this and other studies, many antidepressant consumers are pursuing Cymbalta lawsuits and may choose to join a Cymbalta withdrawal symptoms class action lawsuit in the future.